Skip to main content
SpringerLink
Log in

Sind atypische Antipsychotika Mittel erster Wahl bei bipolaren Störungen? Kontra

Are atypical antipsychotic drugs the first line treatment for bipolar disorders? Against

  • Pro und Kontra
  • Published:
Der Nervenarzt Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Lohse MJ, Müller-Oerlinghausen B (2011) Psychopharmaka. In: Schwabe U, Paffrath D (Hrsg) Arzneiverordnungsreport 2011. Springer, Berlin

  2. Hirschowitz J, Kolevzon A, Garakami A (2010) The pharmacological treatment of bipolar disorders: the question of modern advances. Harv Rev Psychiatry. DOI 0.3109/10673229.2010.507042

  3. Weiner M, Warren L, Fiedorowicz JG (2011) Cardiovascular morbidity and mortality in bipolar disorder. Ann Clin Psychiatry 23:40–47

    PubMed  Google Scholar 

  4. Goodwin GM, Malhi GS (2007) What is a mood stabilizer? Psychol Med 37:609–614

    Article  PubMed  Google Scholar 

  5. Lewitzka U, Bauer M, Felber W, Müller-Oerlinghausen B (2012) Suizidprophylaktische Wirkung von Lithium. Nervenarzt. DOI 10.1007/s00115-012-3542-5

  6. Bellivier F, Yon L, Luquiens A et al (2011) Suicidal attempts in bipolar disorder: results from an observational study (EMBLEM). Bipol Dis 13:377–386

    Article  Google Scholar 

  7. Grof P, Müller-Oerlinghausen B (2009) A critical appraisal of lithium’s efficacy and effectiveness: the last 60 years. Bipol Dis 11(Suppl 2):10–19

    Article  CAS  Google Scholar 

  8. Pfennig A, Schlattmann P, Alda M et al (2011) Influence of atypical features on the quality of prophylactic effectiveness of long-term lithium treatment in bipolar disorders. Bipol Dis 12:390–396

    Article  Google Scholar 

  9. DGBS e. V., DGPPN e. V. (2012) S3-Leitlinie zur Diagnostik und Therapie Bipolarer Störungen. Langversion 1.0, Mai 2012

  10. Tsai AC, Rosenlicht NZ, Jureidini JN et al (2011) Aripiprazole in the maintenance treatment of bipolar disorder: a critical review of the evidence and its dissemination into the scientific literature. PLoS Med 8:e1000434

    Article  PubMed  CAS  Google Scholar 

  11. Correll CU, McKane J, Manu P (2011) Obesity and coronary risk in patients treated with second-generation antipsychotics. Eur Arch Psychiatry Clin Neurosci 261:417–423

    Article  PubMed  Google Scholar 

  12. Gentile S (2007) Atypical antipsychotics for the treatment of bipolar disorder. More shadows than lights. CNS Drugs 21:367–387

    Article  PubMed  CAS  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

  1. -, Bartningallee 11-13, 10557, Berlin, Deutschland

    B. Müller-Oerlinghausen

Authors
  1. B. Müller-Oerlinghausen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to B. Müller-Oerlinghausen.

Additional information

Dieser Beitrag ist Teil einer Pro-und-Kontra-Debatte. Den zugehörigen Pro-Standpunkt finden Sie unter http://dx.doi.org/10.1007/s00115-012-3618-2.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Müller-Oerlinghausen, B. Sind atypische Antipsychotika Mittel erster Wahl bei bipolaren Störungen? Kontra. Nervenarzt 83, 1191–1192 (2012). https://doi.org/10.1007/s00115-012-3619-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00115-012-3619-1

Search

Navigation